|
Market Closed -
NYSE
06:00:00 20/08/26 am AEST
|
5-day change | 1st Jan Change | ||
| 1.100 USD | +3.77% |
|
0.00% | -34.13% |
| 07/08 | Lineage Cell Therapeutics, Inc., Q2 2026 Earnings Call, Aug 06, 2026 | |
| 07/08 | Lineage Cell Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +3.77% | 0.00% | 0.00% | -8.33% | -34.13% | -11.29% | -19.71% | -52.79% | -65.08% | 268M | |
| +2.37% | +0.66% | +2.01% | +23.68% | +7.70% | +4.21% | +22.74% | -23.04% | +210.90% | 48.63B | |
| -0.62% | +4.58% | +19.00% | +45.73% | +169.50% | +487.47% | +618.65% | +772.96% | - | 46.3B | |
| +2.09% | +4.96% | +21.34% | +26.88% | +24.04% | +20.59% | +92.16% | +36.82% | +1,173.18% | 41.97B | |
| +3.85% | +3.13% | +22.26% | +43.94% | +10.59% | +29.60% | +16.29% | -2.88% | +232.15% | 39.51B | |
| -0.72% | -7.79% | +10.41% | +11.25% | +12.60% | +17.87% | +47.98% | -13.84% | +143.79% | 31.75B | |
| +3.04% | +1.89% | +15.22% | +44.86% | +8.30% | +31.62% | +147.28% | +244.69% | +2,032.04% | 16.48B | |
| +4.33% | +1.63% | +3.12% | +9.09% | - | - | - | - | - | 16.34B | |
| +1.44% | +1.09% | +0.54% | +17.61% | +13.24% | +4.93% | +31.00% | -39.75% | +90.97% | 14B | |
| +3.87% | +1.98% | +32.00% | +90.25% | +45.38% | +82.99% | +44.34% | -31.01% | +250.83% | 13.33B | |
| +3.26% | +3.18% | +3.80% | +51.91% | -5.34% | -3.98% | -30.68% | -30.05% | +128.04% | 12.89B | |
| -5.28% | +1.81% | +36.56% | +83.94% | +70.42% | +56.59% | +78.26% | -40.91% | - | 12.68B | |
| +0.36% | +0.35% | +1.17% | +59.40% | +23.24% | +32.09% | -7.88% | -39.08% | +170.57% | 11.25B | |
| +0.39% | -6.09% | -13.34% | +8.05% | -14.20% | +73.03% | +504.09% | +290.55% | +2,359.52% | 10.27B | |
| +4.42% | -0.04% | +26.86% | +20.45% | +31.03% | +762.13% | +1,675.59% | +54.82% | - | 10.33B | |
| -1.53% | +1.93% | +15.39% | +57.51% | +77.40% | +175.45% | +693.34% | +221.25% | +1,213.05% | 10.18B | |
| +0.10% | +0.12% | +0.42% | +72.11% | +78.47% | +269.98% | +454.36% | - | - | 10.15B | |
| +4.89% | +11.65% | +14.63% | +62.93% | +63.62% | +199.06% | +526.22% | +144.78% | - | 10.09B | |
| +1.98% | +7.55% | +14.83% | -17.66% | -23.14% | +43.13% | +55.10% | +60.68% | +82.09% | 9.91B | |
| +24.09% | +12.16% | +26.52% | +34.53% | +3.73% | -16.19% | - | - | - | 8.91B | |
| Average | +2.78% | -0.31% | +12.64% | +36.91% | +29.60% | +118.91% | +274.95% | +91.36% | +617.08% | 18.76B | |
| Weighted average by Cap. | +2.09% | +0.10% | +13.80% | +36.26% | +39.73% | +121.30% | +227.85% | +133.08% | +584.72% |
- Stock Market
- Stocks
- LCTX Stock
- Sector Lineage Cell Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
